Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD - Docwire News Doc Wire News, 02 May 2021 This article was originally published here BMC Neurol. 2021 May 1;21(1):183. doi: 10.1186/s12883-021-02218-4.